LSE - Delayed Quote GBp
Celadon Pharmaceuticals Plc (CEL.L)
4.5000
0.0000
(0.00%)
At close: May 2 at 11:30:29 AM GMT+1
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. James Gareth Short | Co-Founder, CEO & Executive Director | 245k | -- | 1968 |
| Mr. Paul Allen | Co-Founder | -- | -- | -- |
| Iqbal Gill | Chief Scientific Officer | -- | -- | -- |
| Ms. Kerin Williams | Company Secretary | -- | -- | 1970 |
Celadon Pharmaceuticals Plc
71-75 Shelton Street
London, WC2H 9JQ
United Kingdom
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 27
Description
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products. Its products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Corporate Governance
Celadon Pharmaceuticals Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 12, 2025 at 7:30 AM UTC - May 16, 2025 at 7:30 AM UTC
Celadon Pharmaceuticals Plc Earnings Date
Recent Events
Recent Events Information Not Available